@article{4251ec1a04b644e28b0f286f27dcf358,
title = "In Response to Dr. Knisely and Colleagues",
author = "Vinai Gondi and Ranjini Tolakanahalli and Mehta, \{Minesh P.\} and Tom{\'e}, \{Wolfgang A.\}",
note = "Disclosures: Dr. Mehta has served as a consultant to Adnexus, Bayer, Genenteh, Merck, Schering Plough, and Tomotherapy; he serves on the Board of Directors of Pharmacyclics and as an advisor to Stemina, and is on the DSMB for Apogenix. He holds stock options in Pharmacyclics and Tomotherapy.",
year = "2011",
month = mar,
day = "1",
doi = "10.1016/j.ijrobp.2010.10.044",
language = "American English",
volume = "79",
journal = "International Journal of Radiation Oncology Biology Physics",
}